Because the peripheral iris is imprisoned between the claws, the iris-claw lens can be fastened to the iris without sutures, allowing for a quick implantation. As a result, when compared to combo surgery, the hypotonic open sky period is shortened. The goal of this study was to evaluate if retropupillary iris-claw intraocular lens insertion was safe and successful in our facility. was to see if retropupillary iris-claw intraocular lens insertion was safe and successful in our institution. Methods: A total of 36 eyes with aphakia without capsular support were included in this prospective study. Before obtaining retropupillary iris-claw intraocular lens implantation, all of the patients were extensively checked. The average age of the patients was 63.6 years, with a standard deviation of 10.5 years. The age range of 60-70 years had the highest number of cases (46 percent ). Patients were followed for an average of 3.1 years, ranging from one month to six years. 25 (69%) of the 36 eyes had visual acuity of 6/9, five (14% ) of the eyes had 6/12, three eyes (8%) had 6/6 vision, two eyes had 6/24, and one eye only had sense of light and projection of rays. The most common surgical complication was subconjunctival haemorrhage, which occurred in 13 (36%) of patients. In the postoperative period, two eyes developed secondary glaucoma due to pupillary blockage. Retinal detachment was visible in one eye. Until the most recent fol Conclusion: In such patients, retropupillary iris-claw implantation is the safest and most effective therapy option currently available, according to our findings and those of other studies.

Author (s) Details

Dr. Suraya Kounser
Department of Ophthalmology, SKIMS Medical College, Srinagar, India.

Dr. Khurshid Ahmad
Surgeon Health Services, Jammu and Kashmir, India.

Dr. Shiekh Sajjad
Department of Ophthalmology, SKIMS Medical College, Srinagar, India.

View Book :- https://stm.bookpi.org/HMMS-V11/article/view/2509